SAINT LOUIS, MO, June 12, 2023 – NewLeaf Symbiotics, an innovative agricultural biotechnology company, is pleased to announce the appointment of David Purschke as its new Vice President of Finance. With a proven track record in financial management and a diverse skill set in accounting, reporting, and financial analysis, Purschke brings valuable expertise to support NewLeaf Symbiotics’ ambitious growth plan.
Purschke’s experience spans over two decades, encompassing significant roles in finance and accounting across various industries. He holds an M.B.A. degree from Washington University and a B.S. in Business Administration from the University of Missouri – St. Louis. As a Certified Public Accountant (CPA), Purschke’s qualifications demonstrate his commitment to excellence and professionalism in the field of finance.
Prior to joining NewLeaf Symbiotics, Purschke served as the Director of Finance at Spartech, LLC, where he successfully established and managed general accounting functions, guiding the company through audits and financial evaluations during its sale process. He also held leadership positions at Energizer Holdings, Inc., contributing to the company’s financial operations and strategic planning.
“We are excited to welcome David Purschke as our new VP of Finance,” said Brent Smith, President of NewLeaf Symbiotics. “With his extensive financial background and expertise, Purschke brings a vitally important skill set to our organization. As part of our leadership team he will bring the rigor and discipline to help manage our rapid growth.”
“Joining NewLeaf Symbiotics is an exciting opportunity,” said David Purschke. “Their pioneering approach to sustainable agriculture aligns perfectly with my values. I look forward to leveraging my financial expertise to drive their initiatives and contribute to their leadership in the agricultural biotechnology industry.”
David Purschke’s appointment reflects NewLeaf Symbiotics’ commitment to attracting top talent and strengthening its financial capabilities. With Purschke’s financial leadership, NewLeaf Symbiotics is well-positioned to advance its growth initiatives and make a lasting impact in the agricultural biotechnology industry.
About NewLeaf Symbiotics
NewLeaf Symbiotics is an agricultural biologicals company that discovers, develops, produces, and commercializes products containing beneficial plant microbes. Its team has grown to 35+ members including 12 PhD scientists. NewLeaf has filed over 150 patents and patent applications and introduced its first biostimulant products in the US for corn and soy, Terrasym 450 and Terrasym 401.